Anhui Anke Biotechnology (300009.SZ) appoints Yuan Chun as Co-CEO and Chief Commercial Officer.

Ankon Biology (300009.SZ) issued an announcement that the Ninth Board of Directors of the company approved the appointment of Mr. Yuan Chun as the Co-CEO and Chief Commercial Officer of the company during the Fifth Meeting of the Ninth Board of Directors. Mr. Yuan Chun will work with Dr. Dou Changlin, who was previously appointed as the Co-CEO and Chief Scientific Officer, reporting directly to the Chairman and President of the Board of Directors. Mr. Yuan Chun will be responsible for overseeing the company's sales management, operating the marketing system, and building the brand. He will anchor the globalization development strategy, establish an excellent marketing system, promote the introduction of cutting-edge products, achieve local and global marketing synergy, and enhance the company's overall strength. His term of office will last from the date of approval by the Board of Directors to the expiry date of the current term of the Board of Directors.